Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ITI Pharma and Healthcare Fund · Direct ✕Edelweiss Recently Listed IPO Fund · Direct ✕

Growth of ₹10,000

Basics

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseITIEdelweiss
NAV₹20.7004₹36.4592
NAV date20 Nov 202620 Nov 2026
History5.0 years8.7 years
Expense ratio0.9%1.4%
Stars★★★★★★★★★★
Growth Score72.8045.20

Returns

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
1 month+11.35%+5.92%
3 months+4.42%+2.40%
6 months+12.33%+20.35%
YTD+21.31%+25.20%
1 year+18.01%+23.75%
3 years (CAGR)+19.94%+17.13%
5 years (CAGR)+15.73%+11.04%
10 years (CAGR)——
Since launch+15.56%+15.95%

Risk

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Volatility15.9%20.9%
Downside volatility10.1%12.9%
Sharpe0.850.51
Sortino1.340.82
Calmar1.170.69
Return / risk1.250.82
Deepest fall−17.69%−32.34%
Days to recover364155
Below its high+0.00%−1.63%

Against benchmark

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Alpha−1.30%+5.69%
Beta0.980.97
R²84.6%56.3%
Up capture94.1%114.2%
Down capture98.8%93.5%
Tracking error6.2%13.8%
Information ratio−0.260.40
Treynor0.130.10

Consistency

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Best 1-year+61.91%+98.01%
Middle 1-year+15.57%+17.30%
Worst 1-year−9.32%−23.25%
1-year periods with a loss21.7%23.7%
Middle 3-year+21.36%+18.97%
Positive months72.2%66.7%
Best day+3.48%+3.68%
Worst day−3.28%−5.79%
Worst 5% day−1.48%−1.93%
Positive days56.0%57.6%
NAVs a year247247

SIP of ₹10,000 a month

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
5-year XIRR—+17.87%
5-year value—₹9,45,521
3-year XIRR+15.60%+18.35%
1-year XIRR+27.81%+35.31%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth